XIAOCUI WANG
No ORCID on file
· 15 papers in corpus
· active 2009-2014
Study types
- article 2
Condition tags
- endometriosis 2
Top journals
Frequent coauthors
- YANG YANG 15
- XIAOYU XU 15
- YI CHEN 14
- JIFEN ZHANG 14
- AO LI 13
- ZHUOHENG LI 13
- LAN YE 13
- BINBIN FENG 13
- WEI DONG 13
- Gang Chen 2
article
2014
Ethnopharmacological relevanceFerulic acid (FA), ligustrazine (LZ) and tetrahydropalmatine (THP) are separately isolated from Chinese Angelica, Szechwan Lovage Rhizome and Rhizoma in the Jiawei-Foshou-San formula, a popular traditional Chin…
article
2011
OBJECTIVE: To explore the effect and mechanism of Jiawei Foshou San on the accretion ectopic endometrium of rats. METHOD: Endometriosis model was established by surgical implant of endometrial tissue which belongs to its body in rats. Jiawe…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…
2009
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…